Phosphorothioate oligonucleotides inhibit the intrinsic tenase complex

Blood

Volumn 92, Issue 5, 1998, Pages 1617-1625

  Sheehan, John P ^a,b   Lan, Hao Chang ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Department of Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALICAFORSEN; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 11A; BLOOD CLOTTING FACTOR 5A; BLOOD CLOTTING FACTOR 8A; BLOOD CLOTTING FACTOR 9A; CALCIUM; FIBRINOGEN; HEPARIN COFACTOR II; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; PHOSPHOLIPID; PROTHROMBIN; THROMBIN; THROMBOPLASTIN; UNCLASSIFIED DRUG; VIPER VENOM;

ANTICOAGULATION; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBIN TIME;

EID: 0032170976     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.5.1617.417k13_1617_1625     Document Type: Article

References (27)

1. Crooke ST, Bennett CF: Progress in antisense oligonucleotide therapeutics. Annu Rev Pharmacol Toxicol 36:107, 1996
2. A roundtable on the state of the industry. Presented at the Antisense 1997 Conference, May 1-2, 1997, Cambridge, MA. Nat Biotechnol 15:519, 1997
3. Diamond MS, Staunton DE, de Fougerolles AR, Stacker SA, Garcia-Aguilar J, Hibbs ML, Springer TA: ICAM-1 (CD54): A counter-receptor for Mac-1 (CD11b/CD18). J Cell Biol 111:3129, 1990
4. Marlin SD, Springer TA: Purified intercellular adhesion molecule-1 (ICAM-1 ) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 51:813, 1987
5. Bennet CF, Dean N, Ecker DJ, Monia BP: Pharmacology of antisense therapeutic agents: Cancer and inflammation, in Agrawal S (ed): Methods in Molecular Medicine: Antisense Therapeutics. Totowa, NJ, Humana Press Inc, 1995, p 13
6. Yacyshyn B, Bowen-Yacyshyn MB, Jewell L, Tami JA, Bennet CF, Kisner DL, Shanahan WR: A placebo-controlled trial of ISIS 2302 (ICAM-J antisense oligodeoxynucleotide) in the treatment of Crohn's disease. Gastroenterology 114:1133, 1998
7. Altmann KH, Fabbro D, Dean NM, Geiger T, Monia B, Muller M, Nicklin P: Second-generation antisense oligonulceorides: Structure-activity relationships and the design of improved signal transduction inhibitors. Biochem Soc Trans 24:630, 1996
8. Baker BF, Lot SS, Condon TP, Cheng-Flournoy S, Lesnik EA, Sasmor HM, Bennett CF: 2′-O-(2-Methoxy)ethyl-modified anti- intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells. J Biol Chem 272:11994, 1994
9. Morvan F, Sanghvi YS, Perbost M, Vasseur JJ, Bellon L: Oligonucleotide mimics for antisense therapeutics: Solution phase and automated solid-support synthesis of MMI linked oligomers. J Am Chem Soc 118:255, 1996
10. Henry SP, Boite H, Auletta C, Kornbrust DJ: Evaluation of the toxicity of ISIS 2302, a phosphorothioate oligonucleotide, in a four-week study in cynomolgus monkeys. Toxicology 120:145, 1997
11. Henry SP: Inhibition of coagulation by a phosphorothioate oligonucleotide. Antisense Nucleic Acid Drug Dev 7:503, 1997
12. Henry SP, Giclas PC, Leeds J, Pangburn M, Auletta C, Levin AA, Kornbrust DJ: Activation of the alternative pathway of complement by a phosphorothioate oligonucleotide: Potential mechanism of action. J Pharmacol Exp Ther 281:810, 1997
13. Guakova MA, Yakubov LA, Vlodavsky I, Tonkinson JL, Stein CA: Phosphorothioate oligodeoxynucleotides bind to basic fibroblast growth factor, inhibit its binding to cell surface receptors, and remove it from low affinity binding sites on extracellular matrix. J Biol Chem 270:2620, 1995
14. Sheehan JP, Sadler JE: Molecular mapping of the heparin-binding exosite of thrombin. Proc Natl Acad Sci USA 91:5518, 1994
15. Lollar P, Parker CG, Tracy RP: Molecular characterization of commercial porcine factor VIII concentrate. Blood 71:137, 1988
16. Wu QY, Sheehan JP, Tsiang M, Lentz SR, Birktoft JJ, Sadler JE: Single amino acid substitutions dissociate fibrinogen-clotting and thrombomodulin-bindrng activities of human thrombin. Proc Natl Acad Sci USA 88:6775, 1991
17. Duffy EJ, Lollar P: Intrinsic pathway activation of factor X and its activation peptide-deficient derivative, factor Xdes-143-191. J Biol Chem 267:7821, 1992
18. Funk C, Gmur J, Herold R, Straub PW: Reptilase R - A new reagent in blood coagulation. Br J Haematol 21:43, 1971
19. Bock LC, Griffin LC, Latham JA, Vermass EH, Toole JJ: Selection of single stranded DNA molecules that bind and inhibit human thrombin. Nature 355:564, 1992
20. Sheehan JP, Tollefsen DM, Sadler JE: Heparin cofactor II is regulated allosterically and not primarily by template effects. Studies with mutant thrombins and glycosaminoglycans. J Biol Chem 269: 32747, 1994
21. Church FC, Pratt CW, Treanor RE, Whinna HC: Antithrombin action of phosvitin and other phosphate-containing polyanions is mediated by heparin cofactor IL FEBS Lett 237:26, 1988
22. Olson ST, Bjork I, Sheffer R, Craig PA, Shore JD, Choay J: Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement. J Biol Chem 267:12528, 1992
23. Rand MD, Lock JB, vant Veer C, Gaffney DP, Mann KG: Blood clotting in minimally altered whole blood. Blood 88:3432, 1996
24. Barrow RT, Parker ET, Krishnaswamy S, Lollar P: Inhibition by heparin of the human blood coagulation intrinsic pathway factor X activator. J Biol Chem 269:26796, 1994
25. Crooke ST, Lemonidis KM, Neilson L, Griffey R, Lesnik EA, Monia BP: Kinetic characteristics of Escherichia coli RNase HI: Cleavage of various antisense oligonucleotide-RNA duplexes. Biochem J 312:599, 1995
26. Gray E, Cesmeli S, Lormeau JC, Davies AB, Lane DA: Low affinity heparin is an antithrombotic agent. Thromb Haemost 71:203, 1994
27. Lawson JH, Kalafatis M, Stram S, Mann KG: A model for the tissue factor pathway to thrombin. I. An empirical study. J Biol Chem 269:23357, 1994